For: | Karras SN, Koufakis T, Zebekakis P, Kotsa K. Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun. World J Diabetes 2019; 10(4): 234-240 [PMID: 31040899 DOI: 10.4239/wjd.v10.i4.234] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v10/i4/234.htm |
Number | Citing Articles |
1 |
Ehsan Heidari, Arman Shafiee, Shahab Noorian, Mohammad Ali Rafiei, Mohammad Abbasi, Mohammad Javad Amini, Omid Safari, Fatemeh Aghamahdi, Mahmood Bakhtiyari. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials. Diabetes/Metabolism Research and Reviews 2024; 40(4) doi: 10.1002/dmrr.3806
|
2 |
Jane Carissa Sutedja, Bryan Gervais de Liyis, Made Ratna Saraswati. Gamma-aminobutyric acid for delaying type 1 diabetes mellitus: an update. Annals of Pediatric Endocrinology & Metabolism 2024; 29(3): 142 doi: 10.6065/apem.2346184.092
|
3 |
Aram Minas, Hatef Talebi, Morteza Taravat Ray, Mohammad Yari Eisalou, Marco G. Alves, Mazdak Razi. Insulin treatment to type 1 male diabetic rats protects fertility by avoiding testicular apoptosis and cell cycle arrest. Gene 2021; 799: 145847 doi: 10.1016/j.gene.2021.145847
|
4 |
Mariel Lechner. Adjunctive Therapies for Weight Management in Type 1 Diabetes. ADCES in Practice 2023; 11(1): 28 doi: 10.1177/2633559X221136868
|
5 |
Omolola R. Oyenihi, Marlon E. Cerf, Motlalepula G. Matsabisa, Nicole L. Brooks, Oluwafemi O. Oguntibeju. Effect of kolaviron on islet dynamics in diabetic rats. Saudi Journal of Biological Sciences 2022; 29(1): 324 doi: 10.1016/j.sjbs.2021.08.095
|
6 |
Djordje S Popovic, Nikolaos Papanas, Ioanna Zografou, Dimitrios Patoulias, Theocharis Koufakis. Drawing lines in the sand: The growing threat of obesity in type 1 diabetes. World Journal of Diabetes 2024; 15(5): 823-827 doi: 10.4239/wjd.v15.i5.823
Abstract(200) |
Core Tip(231) |
Full Article(HTML)(734)
|
Full Article with Cover (PDF)-895K(48)
|
Full Article (Word)-45K(1)
|
Audio-875K(5)
|
Peer-Review Report-383K(17)
|
Answering Reviewers-139K(18)
|
Full Article (PDF)-376K(84)
|
Full Article (XML)-66K(18)
|
Times Cited (2)
|
Total Visits (2112)
|
Open
|
7 |
Klara R. Klein, Jennifer L.R. Freeman, Imogene Dunn, Chris Dvergsten, M. Sue Kirkman, John B. Buse, Carmen Valcarce, John B. Buse, Klara R. Klein, M. Sue Kirkman, Katherine A. Bergamo, Elizabeth H. Harris, Jean M. Dostou, Laura A. Young, Sriram Machineni, Alex M. Kass, Jamie C. Diner, Milana Dezube, Virginia C. Purrington, Julie M. Uehling, Rachael M. Fraser, Katherine R. Schuch, Jennifer V. Rowell, Ali Qamar, K. Jean Lucas, Luke Snedaker, Stephanie Hoover, Justin Smith, Paul Becton, Jeffrey Hainsworth, Timothy S. Bailey, Juan Pablo Garcia-Naranjo, Niki Nguyen, Bruce W. Bode, Jennifer M. Boyd, Betsy Childs, Pablo Mora, Allison Camacho, Carl D. Vance, Karen Lugo, Anuj Bhargava, Kirstie Stifel, Lisa B. Connery, Birjis Khan, Simone D. Smith, John Parker, Kathryn Zweier, Emily Kronenfeld, Brittany Savoca, Viral N. Shah, Prakriti Joshee, Shivani Dixit, Hal Joseph, Halis Kaan Akturk, Subbulaxami Trikudanathan, Dori Khakpour, Julia Chang, Anne Peters, Pejman Cohan, Mark Harmel, Wendy S . Lane. The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes. Diabetes Care 2021; 44(4): 960 doi: 10.2337/dc20-2684
|